logo
Plus   Neg
Share
Email

ImaginAb, AstraZeneca, Pfizer, Takeda Join To Develop CD8 ImmunoPET Technology

ImaginAb, Inc., a clinical-stage immuno-oncology imaging company, announced Monday that it has signed a multi-party collaboration deal with AstraZeneca Plc (AZN.L,AZN), Pfizer Inc. (PFE) and Takeda Pharmaceutical Co. Ltd. The agreement is focused on furthering the clinical development of ImaginAb's CD8 ImmunoPET technology.

Under the deal terms, the collaborators will help guide a current ImaginAb-sponsored clinical trial that aims to evaluate the utility and value of CD8 ImmunoPET in immuno-oncology drug development.

In return, the collaborators will gain early access to clinical and imaging data and collectively contribute to the post-trial data analysis.

The ImmunoPET technology uses ImaginAb's 'Minibody' platform, and targets and visualizes CD8+ T cells to provide highly-specific, quantitative assessment of the immunological status of each cancer lesion within a patient. This helps to tailor treatment quickly and specifically to the needs of that patient.

Ian Wilson, Chief Executive Officer of ImaginAb, said, " We believe that working with global leaders in immuno-oncology will help us further develop CD8 ImmunoPET as a pharmacodynamic marker for use in drug development and, in the future, as a diagnostic and predictive test for use in hospitals."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Motors Co. (GM) is hiring for new workforce, after cutting about some 4,000 salaried employees early this year. According to Detroit Free Press, the auto giant is hiring for a new workforce as the company invests more money to develop electric and self-driving vehicles. Earlier this year,... Australia's Federal Court has ruled in favor of more than 1,000 women in a landmark class-action lawsuit against Johnson & Johnson after they suffered severe pain and complications from the healthcare giant's pelvic mesh implants. Johnson & Johnson and its subsidiary Ethicon were accused of hiding the risks of its pelvic mesh products. SpaceX's Starship rocket prototype was damaged while undergoing pressurization testing on Wednesday evening. Video from the vicinity of SpaceX's Boca Chica test facility in Texas showed white plumes erupt from the top part of the Starship Mark 1 vehicle while it was undergoing a pressurization test. The eruption blew off the upper bulkhead high into the air.
Follow RTT
>